article_metadata: S Morteza Seyed Jafari Laurence Feldmeyer Simon Bossart Dagmar Simon Christoph Schlapbach Luca Borradori
article_metadata: 10.3389/fimmu.2020.611549
article_metadata: Front Immunol
article_metadata: 2021 Jan 29;11:611549.
article_metadata: bullous pemphigoid dupilumab omalizumab recalcitrant treatment
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/33584689/
article_metadata: Antibodies, Monoclonal, Humanized / therapeutic use Omalizumab / therapeutic use Pemphigoid, Bullous / drug therapy Skin / drug effects
article_metadata: Antibodies, Monoclonal, Humanized / therapeutic use Omalizumab / therapeutic use Pemphigoid, Bullous / drug therapy Skin / drug effects Case Reports Research Support, Non-U.S. Gov't Aged Drug Therapy, Combination Humans Male Pemphigoid, Bullous / diagnosis Pemphigoid, Bullous / immunology Remission Induction Skin / immunology Skin / pathology Treatment Outcome Antibodies, Monoclonal, Humanized Omalizumab dupilumab
article_metadata: PMC7879677
article_metadata: 33584689
article_metadata: Case Report: Combination of Omalizumab and Dupilumab for Recalcitrant Bullous Pemphigoid
article_metadata: 2021